Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.

In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.

  • Focuses on translational research
  • Addresses the conversion of cell biology to clinical applications

Journal information

Editors-in-Chief
  • Begoña Diosdado,
  • Ad Geurts van Kessel
Publishing model
Hybrid. Open Access options available

Journal metrics

5.02 (2018)
Impact factor
3.500 (2018)
Five year impact factor
21 days
Submission to first decision
191 days
Submission to acceptance
53,223 (2018)
Downloads

Latest articles

  1. Authors (first, second and last of 5)

    • Vincent F.M. Segers
    • Lindsey Dugaucquier
    • Gilles W. De Keulenaer
    Content type: Review
This journal has 75 open access articles

Journal updates

  • Impact of COVID-19 on journal operations

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

    COVID-19
View all updates

Subscribe

  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2020

Advertisement

About this journal

Electronic ISSN
2211-3436
Print ISSN
2211-3428
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. CNKI
  5. Chemical Abstracts Service (CAS)
  6. Current Contents/ Life Sciences
  7. Current Contents/Clinical Medicine
  8. EBSCO Academic Search
  9. EBSCO Advanced Placement Source
  10. EBSCO Biomedical Reference Collection
  11. EBSCO Discovery Service
  12. EBSCO STM Source
  13. EMBASE
  14. Elsevier Biobase
  15. Google Scholar
  16. Institute of Scientific and Technical Information of China
  17. Japanese Science and Technology Agency (JST)
  18. Journal Citation Reports/Science Edition
  19. Medline
  20. Meta
  21. Naver
  22. OCLC WorldCat Discovery Service
  23. ProQuest Biological Science Database
  24. ProQuest Central
  25. ProQuest Natural Science Collection
  26. ProQuest SciTech Premium Collection
  27. ProQuest-ExLibris Primo
  28. ProQuest-ExLibris Summon
  29. Reaxys
  30. SCImago
  31. SCOPUS
  32. Science Citation Index
  33. Science Citation Index Expanded (SciSearch)
Copyright information

Rights and permissions

Springer policies

© International Society for Cellular Oncology